for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

Breakingviews TV: Array factor

Pfizer is buying Array BioPharma for $11 billion, a 62% premium. It’s Big Pharma buying another smallish biotech, but in this case, Array’s backstory is a mix of skill, law and luck, as Rob Cyran explains.

最新のビデオ
世界のこぼれ話
スポーツ

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up